Anzeige
Mehr »
Login
Dienstag, 25.02.2020 Börsentäglich über 12.000 News von 619 internationalen Medien
Mega-Chance Palladium: Europäischer Palladiumjunior von der Masse noch völlig unentdeckt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0MZH8 ISIN: AU000000ACW3 Ticker-Symbol: 3AC 
Frankfurt
24.02.20
08:33 Uhr
0,012 Euro
-0,002
-11,54 %
Branche
Biotechnologie
Aktienmarkt
AUSTRALIEN
1-Jahres-Chart
ACTINOGEN MEDICAL LIMITED Chart 1 Jahr
5-Tage-Chart
ACTINOGEN MEDICAL LIMITED 5-Tage-Chart

Aktuelle News zur ACTINOGEN Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoACTINOGEN MEDICAL LIMITED: Appendix 4D & Half-Year Financial Statements-
16.02.ACTINOGEN MEDICAL LIMITED: Additional R&D Tax Incentive rebate received2
31.01.ACTINOGEN MEDICAL LIMITED: Appendix 3Y-Dr Bill Ketelbey6
ACTINOGEN Aktie jetzt für 4€ handeln
31.01.ACTINOGEN MEDICAL LIMITED: ASIC Form 4842
31.01.ACTINOGEN MEDICAL LIMITED: Final share buy-back notice - Appendix 3F3
27.01.ACTINOGEN MEDICAL LIMITED: December 2019 Quarterly Update3
07.01.ACTINOGEN MEDICAL LIMITED: Actinogen at SACHS Forum and JP Morgan week2
17.12.19ACTINOGEN MEDICAL LIMITED: Review of 2019 and outlook4
13.12.19ACTINOGEN MEDICAL LIMITED: Share Cancellation - Employee Share Plan2
26.11.19ACTINOGEN MEDICAL LIMITED: Managing Director share loan repayment-
25.11.19ACTINOGEN MEDICAL LIMITED: Results of Annual General Meeting1
24.11.19ACTINOGEN MEDICAL LIMITED: Managing Director's AGM Presentation1
24.11.19ACTINOGEN MEDICAL LIMITED: ACW 2019 AGM Chairman's Address-
20.11.19ACTINOGEN MEDICAL LIMITED: Response to ASX Price Query-
08.11.19VIDEO: 90 Seconds With… Dr. Bill Ketelbey, Actinogen Medical1
24.10.19ACTINOGEN MEDICAL LIMITED: R&D Tax Incentive rebate received of $4.58 million-
24.10.19ACTINOGEN MEDICAL LIMITED: September 2019 Quarterly Update1
22.10.19ACTINOGEN MEDICAL LIMITED: Annual Report to shareholders1
22.10.19ACTINOGEN MEDICAL LIMITED: Notice of Annual General Meeting/Proxy Form-
15.10.19Actinogen Medical - Well-timed XanaHES study saves the day212Actinogen's share price has experienced a rather volatile period since May 2019, when it decreased c 70% following the disappointing Phase II XanADu trial results, only to rebound in October 2019 almost...
► Artikel lesen
Seite:  Weiter >>
34 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1